Tetrahydroaminoacridine
97%
- Product Code: 102731
CAS:
206658-92-6
| Molecular Weight: | 198.26 g./mol | Molecular Formula: | C₁₃H₁₄N₂HClH₂O |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD00150067 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
Tetrahydroaminoacridine is primarily studied for its potential application in the treatment of Alzheimer's disease. It acts as an acetylcholinesterase inhibitor, which helps to increase the levels of acetylcholine in the brain. This can improve cognitive function and memory in patients with Alzheimer's by enhancing communication between nerve cells. Additionally, it has been explored for its neuroprotective properties, which may help to slow the progression of neurodegenerative disorders. Research has also investigated its potential use in other conditions involving cognitive decline, though its efficacy and safety are still under study.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Off-White To Yellow Powder Or Crystals Or Chunks |
| Purity (%) | 96.5-100 |
| Water | 5-10% |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
| Solubility (C=5%, H2O) | Clear Or Hazy Colorless To Faint Yellow Liquid |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿750.00 |
+
-
|
| 0.050 | 10-20 days | ฿2,180.00 |
+
-
|
| 0.250 | 10-20 days | ฿6,550.00 |
+
-
|
Tetrahydroaminoacridine
Tetrahydroaminoacridine is primarily studied for its potential application in the treatment of Alzheimer's disease. It acts as an acetylcholinesterase inhibitor, which helps to increase the levels of acetylcholine in the brain. This can improve cognitive function and memory in patients with Alzheimer's by enhancing communication between nerve cells. Additionally, it has been explored for its neuroprotective properties, which may help to slow the progression of neurodegenerative disorders. Research has also investigated its potential use in other conditions involving cognitive decline, though its efficacy and safety are still under study.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :